about
Live attenuated vaccines for invasive Salmonella infectionsH2-M3 major histocompatibility complex class Ib-restricted CD8 T cells induced by Salmonella enterica serovar Typhimurium infection recognize proteins released by Salmonella serovar Typhimurium.Salmonella DNA adenine methylase mutants confer cross-protective immunityAdoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cellsBacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice.The Salmonella typhimurium AhpC polypeptide is not essential for virulence in BALB/c mice but is recognized as an antigen during infectionHost adaptation and the emergence of infectious disease: the Salmonella paradigm.Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment CSalmonella enterica serotype typhimurium elicits cross-immunity against a Salmonella enterica serotype enteritidis strain expressing LP fimbriae from the lac promoter.Construction of in-frame aroA deletion mutants of Mannheimia haemolytica, Pasteurella multocida, and Haemophilus somnus by using a new temperature-sensitive plasmid.Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidateNatural and vaccine-mediated immunity to Salmonella Typhimurium is impaired by the helminth Nippostrongylus brasiliensis.Evaluation of the live vaccine efficacy of virulence plasmid-cured, and phoP- or aroA-deficient Salmonella enterica serovar Typhimurium in mice.Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.Toxicity of lipopolysaccharide and of soluble extracts of Salmonella typhimurium in mice immunized with a live attenuated aroA salmonella vaccine.Expression of Escherichia coli virulence usher protein attenuates wild-type SalmonellaRefined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.Evaluation and comparison of molecular techniques for epidemiological typing of Salmonella enterica subsp. enterica serovar dublin.Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.Salmonella DNA adenine methylase mutants elicit protective immune responses to homologous and heterologous serovars in chickensVaccination against Salmonella Infection: the Mucosal Way.Antigenic diversity in Eimeria maxima and the influence of host genetics and immunization schedule on cross-protective immunity.aro mutations in Salmonella enterica cause defects in cell wall and outer membrane integrity.A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.Evaluation of the effectiveness and safety of a genetically modified live vaccine in broilers challenged with Salmonella Heidelberg.Avirulant Salmonella typhimurium strains prevent food allergy in mice.Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model.
P2860
Q27003066-26837AF0-376B-4785-AF09-957E85ED3263Q28513033-B29A0944-B7A2-4A98-986D-CED325E8728FQ33552366-1C5C0011-25E9-4CE8-A75E-D81AF319AD66Q33608920-1FD2CA36-20B1-4ADF-A02A-1D890E9CAF97Q33641324-E4C3E2BC-E0BA-455E-AFB8-AFF534C31DBEQ33756294-C9BC1F67-172E-4C61-AD4A-B64949BB5252Q33938210-10DC8020-EE99-4E26-8F36-406A24AECE4AQ34001326-29D4E2F1-1982-4E1E-B29F-EF32AE01CE40Q34005559-F337E202-EC68-4959-90E5-41B66A2B7BDFQ34143390-FB49A04D-32C7-4A58-9FBE-A658CF4CC4ECQ34543536-17F129E1-FDD8-4735-AA84-B52D3E577D35Q34633967-7CEC8B7A-BD68-4D16-928C-6498BAD73A21Q35186131-084F92B1-7ABF-4441-8E10-C9A66BBDB5A8Q35273267-5F2A42E5-8708-46EA-83D3-9AA29EAA192DQ35781875-F4EDF773-E522-486C-B63F-28F25BCD868AQ35914147-13CFA0AB-A5C4-4875-AF29-4CF44EC763DAQ36281257-111DE880-B079-4A30-8C8B-B61616679B56Q36528465-74F4E722-41B8-4D5F-8CC7-151BCBB289DFQ36950045-33E451B3-7733-4B9A-8214-6B4DA0D6D86AQ36970577-0BD0FABD-9EF4-4873-8FE9-1CA9B4F1C0F4Q37405767-A16834BD-EDD9-4CF1-82CA-AE17599198B2Q38455796-B27D6E6F-A654-4286-A006-2C9FE52AED8FQ39373957-E69BBDAB-BDCD-438A-94C4-A7082DAFB3DFQ39654744-73F6D9B2-8A82-414E-9480-E1211ACA7E67Q41908690-26757AEA-BA3A-42E2-BA78-3410CFC0C519Q42367528-19E05CD8-9856-4229-B789-E791023B334AQ46821670-45E5DF51-3869-4E21-9CF7-884085447811Q49947927-685C5A32-BF75-4753-B653-51DA30F5F84DQ50065059-37F309DA-951C-4341-89F3-BC57715683A0Q50134874-4D143820-BB8F-445D-8F47-C293B8740AD9
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Immunity conferred by Aro- Salmonella live vaccines.
@en
Immunity conferred by Aro- Salmonella live vaccines.
@nl
type
label
Immunity conferred by Aro- Salmonella live vaccines.
@en
Immunity conferred by Aro- Salmonella live vaccines.
@nl
prefLabel
Immunity conferred by Aro- Salmonella live vaccines.
@en
Immunity conferred by Aro- Salmonella live vaccines.
@nl
P2093
P1476
Immunity conferred by Aro- Salmonella live vaccines.
@en
P2093
P304
P356
10.1016/0882-4010(91)90075-L
P577
1991-02-01T00:00:00Z